Just list the questions first
Leave the first two topics there. Give me basic anesthesia drugs and their doses. Drugs that are used from induction to maintenance, everything. Uh, mainly give, uh, give me the drugs that are commonly used, you know, drugs like midazolam, then... So commonly you would use... Give me the general order first, you know, what, uh, all drugs are given in anesthesia first. Uh, just, uh, make me understand the basics. And then general anesthesia, like, um, we give someone midazolam first, then propofol, then, um, I don't know, vecuronium or pancuronium or, uh, rocuronium, something like that. Um... Then also, uh, regional anesthetic drugs and their uses, pre-anesthetic drugs and their uses. Uh, give me these in separate, uh, tables. And some anesthesia equipments, their parts. Their users, also the anesthesia workstation and its details, parts, user, uh, parts, and, uh, various things I need to know about it, and also, um, details of airway management. So yeah, give me comprehensive notes on these topics.
anesthesia workstation machine components diagram

This composite educational image illustrates a '3-in-1' surgical procedure for recurrent patellar dislocation (RPD) alongside an ultrasound-guided adductor canal block (ACB). The left anatomical diagram depicts the surgical components: (1) lateral patellofemoral ligament release to loosen the lateral retinaculum; (2) distal realigning via lower-inner transfer of the tibial tuberosity, shown fixed with two screws; and (3) reconstruction of the medial patellofemoral ligament (MPFL) using a graft tendon. Step (4) demonstrates the needle placement for an adductor canal block relative to the femoral neurovascular bundle. The right panel is a transverse ultrasound scan of the medial mid-thigh, labeled for regional anesthesia. It identifies the sartorius (SA) muscle superficially and the vastus medialis (VM) muscle laterally. Within the adductor canal (outlined in red), the hypoechoic saphenous nerve (SN) and the pulsatile femoral artery (FA) are clearly visible. This figure serves as a clinical guide for orthopedic surgeons and anesthesiologists managing patellar instability through combined surgical correction and regional analgesia.

This infographic illustrates the conceptual framework of a closed-loop Brain-Computer Interface (BCI) system for prosthetic control. The diagram is organized in a circular flow using four main components connected by thick black arrows. At the apex, a sagittal anatomical diagram of a human head shows a brain with highlighted orange cortical activity, representing neural intent or motor planning. Following the clockwise flow, a computer workstation symbolizes the signal processing and decoding of neural data. Below this, a clinical photograph shows a skin-toned prosthetic arm and hand performing a fine motor task: manipulating geometric puzzle pieces on a workbench. This represents the effector output and sensory feedback acquisition. Completing the loop, a second computer workstation symbolizes the encoding of feedback signals back to the user. The illustration demonstrates the integration of neural engineering, neurorehabilitation, and embodiment in advanced prosthetics, highlighting the bidirectional communication required for sophisticated bionic limb function.

Anatomical Diagram/Specimen: This clinical photograph displays a collection of 3D-printed anatomical components intended for the construction of a lumbar neuraxial block task trainer. The specimens, printed in white polylactic acid (PLA) using fused filament fabrication (FFF), include individual lumbar vertebral bodies (T10 through L5), bilateral iliac crests, and the sacrum. The vertebral bodies are arranged linearly on a green cutting mat, showcasing detailed posterior elements including spinous and transverse processes. The iliac crests exhibit characteristic complex, irregular morphology and a porous surface texture typical of layer-by-layer 3D printing. These high-fidelity models, derived from CT DICOM data, serve as realistic palpable landmarks for medical simulation. The educational focus is on the spatial orientation of the lumbar spine, sacrum, and pelvis, highlighting their clinical relevance in anesthesiology for identifying entry points for epidural or spinal anesthesia.
airway management laryngoscopy intubation LMA

This sequence of clinical images demonstrates the four steps of endotracheal intubation (ETI) using a polycarbonate barrier box on an airway trainer manikin. The setup is designed to minimize aerosol exposure during airway management. Step 1: An operator wearing personal protective equipment (PPE), including blue gloves, inserts hands through the rear access ports of the transparent box to begin laryngoscopy. Step 2: The operator uses a Macintosh blade laryngoscope to visualize the glottis while an assistant provides a 7.0 mm cuffed endotracheal tube through a side port. Step 3: The operator inserts the tracheal tube into the trachea. Step 4: The tube is secured, the cuff is inflated, and an Ambu-Bag (manual resuscitator) is connected to begin positive-pressure ventilation. The images highlight the ergonomic constraints and procedural adjustments required when performing direct laryngoscopy within a confined barrier enclosure, commonly utilized in protocols for highly infectious respiratory diseases such as COVID-19.

A high-angle clinical photograph displays standard and advanced airway management equipment for endotracheal intubation, positioned alongside a Laerdal Airway Management Trainer mannequin. The equipment includes three types of laryngoscopes: a conventional Macintosh-style laryngoscope with a metal handle and curved blade, and two video laryngoscopes featuring integrated digital screens and specialized curved blades for enhanced glottic visualization. Also present is a Bag Valve Mask (BVM) for manual ventilation. Centrally located is a clear cuffed endotracheal tube (ETT) with an internal stylet bent into a 'hockey-stick' configuration to facilitate insertion; the ETT includes a visible pilot balloon, connector, and depth markings. Ancillary procedural tools include a ruler for measurement and a digital timer for monitoring intubation time. This setup is typical for anesthesia training, emergency medicine simulation, or comparative studies between direct and video laryngoscopy techniques.

This composite educational image illustrates airway management techniques using the VieScope, a novel Miller-shaped (straight) laryngoscope, in comparison to conventional methods. Panel A displays the device, featuring a transparent acrylic glass tube blade that provides 360-degree circular LED illumination and a blue ergonomic handle with a textured grip. Panel B shows the device being used on a medical manikin, demonstrating the line-of-sight visualization through the lumen of the laryngoscope tube. Panel C illustrates the clinical technique for intubation with this device, where a bougie is first introduced through the VieScope to facilitate subsequent placement of an endotracheal tube; the manikin is shown with a cervical collar, simulating a trauma or difficult airway scenario. Panel D provides a contrast with a traditional Macintosh curved-blade laryngoscope, showing the visualization of the glottic opening during direct laryngoscopy. The content focuses on anesthesiology, emergency medicine, and advanced airway management education, highlighting the structural differences and procedural workflow between straight-tube and curved-blade laryngoscopy.
| Drug | Class | Route | Adult Dose | Purpose |
|---|---|---|---|---|
| Midazolam | Benzodiazepine | Oral / IV | 7.5-15 mg oral; 0.025-0.1 mg/kg IV | Anxiolysis, amnesia, sedation. Most commonly used premedicant |
| Diazepam | Benzodiazepine | Oral | 5-10 mg oral | Anxiolysis, sedation |
| Lorazepam | Benzodiazepine | Oral / IV | 2-4 mg oral (2h pre-op) | Prolonged anxiolysis (used in cardiac surgery) |
| Morphine | Opioid | IM | 0.1-0.2 mg/kg | Analgesia, sedation |
| Pethidine (Meperidine) | Opioid | IM | 1-2 mg/kg | Analgesia, sedation |
| Fentanyl | Opioid | IV | 1-2 mcg/kg | Analgesia |
| Atropine | Anticholinergic | IM / IV | 0.01-0.02 mg/kg | Antisecretion (dries secretions), prevents bradycardia |
| Glycopyrrolate | Anticholinergic | IM / IV | 0.2-0.4 mg | Antisecretion (no CNS penetration, preferred) |
| Ranitidine / Pantoprazole | H2 blocker / PPI | Oral / IV | Ranitidine 150 mg; Pantoprazole 40 mg | Reduce gastric acidity (aspiration prophylaxis) |
| Metoclopramide | Prokinetic | IV / IM | 10 mg | Reduce gastric volume, antiemetic |
| Dexmedetomidine | α2 agonist | IV infusion | 0.5-1 mcg/kg over 10 min | Anxiolysis, analgesia, sedation without respiratory depression |
| Clonidine | α2 agonist | Oral | 3-5 mcg/kg | Anxiolysis, reduce anesthetic requirements |
| Ondansetron | 5-HT3 antagonist | IV | 4-8 mg | PONV prophylaxis |
| Drug | Class | IV Induction Dose | Onset | Duration | Key Notes |
|---|---|---|---|---|---|
| Propofol | Alkylphenol | 1.5-2.5 mg/kg IV (2-2.5 mg/kg in healthy adults) | 45 sec | 5-10 min | Most widely used. Can cause hypotension. Pain on injection. Antiemetic property. |
| Thiopentone (Thiopental) | Barbiturate | 4-6 mg/kg IV | 30-60 sec | 5-15 min | Classic agent. Still used in many countries. Can cause laryngospasm. Contraindicated in porphyria. |
| Ketamine | NMDA antagonist | 1-2 mg/kg IV; 4-6 mg/kg IM | 60 sec (IV) | 15-20 min | Dissociative anesthesia. Maintains BP and HR. Bronchodilator. Causes emergence delirium, hypersalivation. Ideal for hemodynamic compromise and asthmatics. |
| Etomidate | Imidazole | 0.3 mg/kg IV | 30-60 sec | 5-10 min | Minimal cardiovascular effects - ideal in hemodynamically unstable patients. Causes myoclonus, PONV. Inhibits cortisol synthesis (single dose effect brief). |
| Midazolam | Benzodiazepine | 0.1-0.3 mg/kg IV | 2-3 min | 30-60 min | Slower induction. Used for sedation more than full induction. |
| Drug | IV Dose | Duration | Notes |
|---|---|---|---|
| Fentanyl | 1-3 mcg/kg bolus | 30-60 min | Most commonly used intraoperative opioid. Fast onset. |
| Morphine | 0.05-0.2 mg/kg IV | 4-6 hrs | Longer acting. Good for postoperative analgesia. |
| Remifentanil | 0.05-2 mcg/kg/min infusion | Ultra-short (context insensitive) | Metabolized by plasma esterases. Excellent for procedures requiring rapid offset. |
| Pethidine (Meperidine) | 0.5-1 mg/kg IV | 2-4 hrs | Also used for shivering post-op. |
| Sufentanil | 0.1-0.5 mcg/kg | 30-60 min | 5-10x more potent than fentanyl. |
| Drug | Dose | Onset | Duration | Notes |
|---|---|---|---|---|
| Succinylcholine (Suxamethonium) | 1-1.5 mg/kg IV (1.5 mg/kg for RSI) | 60-90 sec | 10-15 min | Only depolarizing agent in use. Fastest onset - gold standard for RSI and emergency intubation. Causes fasciculations, hyperkalemia, malignant hyperthermia, bradycardia. Contraindicated in burns, crush injuries, upper motor neuron lesions. |
| Drug | Duration | Intubating Dose | Maintenance Dose | Notes |
|---|---|---|---|---|
| Vecuronium | Intermediate (25-40 min) | 0.1 mg/kg | 0.01-0.015 mg/kg | Clean hemodynamic profile. No histamine release. Hepatic metabolism. |
| Rocuronium | Intermediate (30-60 min) | 0.6 mg/kg (RSI: 1.2 mg/kg) | 0.1-0.2 mg/kg | Fastest onset among non-depolarizing agents (90 sec). Reversed by Sugammadex. Alternative to succinylcholine for RSI. |
| Atracurium | Intermediate (20-35 min) | 0.5 mg/kg | 0.1-0.2 mg/kg | Hoffman elimination (independent of liver/kidney). Safe in organ failure. Releases histamine. |
| Cisatracurium | Intermediate (40-60 min) | 0.15-0.2 mg/kg | 0.03 mg/kg | Similar to atracurium but NO histamine release. Preferred in ICU patients. |
| Pancuronium | Long (60-120 min) | 0.1 mg/kg | 0.01-0.02 mg/kg | Causes tachycardia (vagolytic). Now less commonly used. |
| Mivacurium | Short (12-20 min) | 0.15-0.2 mg/kg | - | Metabolized by plasma cholinesterase. |
| Drug | Dose | Used With | Notes |
|---|---|---|---|
| Neostigmine | 0.05 mg/kg IV (max 5 mg) | Glycopyrrolate 0.2 mg per 1 mg neostigmine | Anticholinesterase. Reverses non-depolarizing block. Must co-administer anticholinergic. |
| Sugammadex | 2-16 mg/kg IV (dose depends on depth of block) | Nothing needed | Selectively encapsulates rocuronium/vecuronium. Rapid complete reversal. |
| Agent | MAC (%) | Properties | Notes |
|---|---|---|---|
| Sevoflurane | 2% | Non-pungent, rapid induction | Most used for inhalational induction (especially children). Pleasant smell. |
| Isoflurane | 1.15% | Pungent, cardiovascular stable | Most widely used volatile agent globally. Coronary steal risk (controversial). |
| Desflurane | 6% | Least soluble, fastest emergence | Pungent (not for induction). Fastest wake-up. Requires heated vaporizer. |
| Halothane | 0.75% | Non-pungent, sweet smell | Older agent. Causes halothane hepatitis, sensitizes heart to catecholamines. |
| Nitrous Oxide (N₂O) | 104% (IMAC) | Analgesic, carries other agents | Used as carrier gas with O₂ (usually 50:70% mix). Weak anesthetic alone. Contraindicated in pneumothorax, bowel obstruction. |
| Drug | Infusion Rate | Notes |
|---|---|---|
| Propofol | 4-10 mg/kg/hr (TIVA) | Total intravenous anesthesia (TIVA). Antiemetic. Fast emergence. |
| Midazolam | 0.25-1 mcg/kg/min | For hypnosis and amnesia in maintenance. |
| Dexmedetomidine | 0.2-0.7 mcg/kg/hr | Sedation in ICU/procedural. Reduces opioid and anesthetic requirements. |
| Ketamine | 0.5-2 mg/kg/hr infusion | Sub-anesthetic dose for analgesia, especially chronic pain surgery. |
| Remifentanil | 0.05-0.5 mcg/kg/min | Opioid infusion for intraoperative analgesia. |
| Drug | Class | Onset | Duration (plain) | Duration (with epinephrine) | Max Safe Dose | Common Uses |
|---|---|---|---|---|---|---|
| Lignocaine (Lidocaine) | Amide | Fast | 1-2 hrs | 2-3 hrs | 3 mg/kg plain; 7 mg/kg with epi | Spinal, epidural, infiltration, peripheral nerve blocks, topical |
| Bupivacaine | Amide | Medium | 4-8 hrs | 6-10 hrs | 2 mg/kg (max 175 mg) | Spinal (most common), epidural, peripheral blocks. NOT for IV regional (Bier's block - cardiotoxic) |
| Ropivacaine | Amide | Medium | 4-8 hrs | - | 3 mg/kg (max 200 mg) | Epidural, peripheral nerve blocks. Less cardiotoxic than bupivacaine. Vasoconstrictor property. |
| Levobupivacaine | Amide | Medium | 4-8 hrs | - | 2-3 mg/kg | S-enantiomer of bupivacaine. Safer cardiac profile. |
| Cocaine | Ester | Fast | 1 hr | - | 3 mg/kg (max 200 mg) | ONLY local anesthetic that is a vasoconstrictor. Used for nasal/ENT procedures only. |
| Procaine | Ester | Medium | 30-60 min | 1-2 hrs | 7 mg/kg | Spinal, infiltration. Metabolized by plasma cholinesterase. |
| Tetracaine (Amethocaine) | Ester | Slow | 2-4 hrs | 4-6 hrs | 1.5 mg/kg | Spinal, topical ophthalmic. |
| Chloroprocaine | Ester | Very fast | 30-45 min | - | 11 mg/kg | Epidural. Short duration. Rapid metabolism - safe in obstetrics. |
| Technique | Drug | Dose | Level |
|---|---|---|---|
| Spinal (intrathecal) | Bupivacaine 0.5% heavy | 1.5-3 ml (7.5-15 mg) | T4-T10 |
| Spinal | Lignocaine 5% heavy | 1.5-2.5 ml | T4-T10 |
| Epidural | Bupivacaine 0.25-0.5% | 15-20 ml | - |
| Epidural | Lignocaine 2% | 15-20 ml | - |
| Equipment | Description | Use |
|---|---|---|
| Laryngoscope | Handle + blade (Macintosh = curved; Miller = straight) | Direct visualization of vocal cords for intubation |
| Endotracheal Tube (ETT) | Cuffed/uncuffed tube | Secures airway, allows ventilation and delivery of volatile agents |
| Laryngeal Mask Airway (LMA) | Supraglottic device - sits over larynx | Airway maintenance without intubation. Used for short procedures, also as rescue device |
| Oropharyngeal Airway (Guedel) | Curved rigid device | Maintains airway in unconscious patient - prevents tongue falling back |
| Nasopharyngeal Airway | Soft rubber tube via nose | Airway maintenance in semi-conscious/awake patients |
| Bag-Valve-Mask (Ambu Bag) | Self-inflating bag + mask | Manual positive pressure ventilation |
| Video Laryngoscope | Camera-equipped laryngoscope | Improved glottic view, especially in difficult airways |
| Fiberoptic Bronchoscope | Flexible scope | Gold standard for anticipated difficult airway - awake fiberoptic intubation |
| Stylet / Bougie | Stiff wire / gum elastic introducer | Aid ETT placement when cords not fully visible |
| Vaporizer | Agent-specific device on machine | Delivers precise concentrations of volatile anesthetic |
| Capnograph (ETCO₂ monitor) | Waveform CO₂ monitor | Confirms ETT placement, monitors ventilation adequacy |
| Pulse Oximeter | SpO₂ probe | Continuous oxygen saturation monitoring |
| Invasive arterial line | Intra-arterial catheter | Continuous BP monitoring, blood gas sampling in major surgery |


| Circuit | Pressure Range | Components |
|---|---|---|
| High-Pressure Circuit | O₂: up to 2,200 psig → regulated to 45 psig; N₂O: 750 psig → 45 psig | Gas cylinders, cylinder primary pressure regulators |
| Intermediate-Pressure Circuit | 45-55 psig | Pipeline inlets, second-stage regulators, O₂ flush valve, ventilator driving gas |
| Low-Pressure Circuit (LPC) | Below 15 psig | Flow control valves → rotameters → vaporizers → common gas outlet |
| Component | Function |
|---|---|
| Gas cylinders | O₂ (green), N₂O (blue), Air (yellow) - backup supply |
| Pipeline supply | Primary gas source from hospital wall at ~50 psig |
| Pressure regulator | Reduces high cylinder pressure to working pressure |
| Fail-safe valve | Shuts off N₂O if O₂ supply pressure drops - prevents hypoxic mixture |
| Rotameter (flowmeter) | Calibrated glass tube with bobbin - controls and measures gas flow |
| Vaporizer | Agent-specific device that delivers precise % of volatile anesthetic (e.g., sevoflurane, isoflurane, desflurane). Has interlock system - only one vaporizer can be on at a time. |
| O₂ flush valve | Delivers 100% O₂ directly to breathing circuit at 35-75 L/min. Bypasses vaporizer - washes out anesthetic agent. |
| Common gas outlet | Final point where all gases and vapor mix before going to the breathing circuit |
| Breathing circuit (circle system) | Delivers gas to patient. Contains: inspiratory limb, expiratory limb, CO₂ absorber (soda lime), APL valve, reservoir bag, Y-piece connector |
| APL valve (Adjustable Pressure Limiting) | Pops off excess gas - prevents barotrauma during spontaneous breathing |
| CO₂ absorber (Soda lime) | Absorbs exhaled CO₂ in a rebreathing system |
| Reservoir bag (Breathing bag) | 1-3L bag - for manual ventilation and as a reservoir; also monitors breathing |
| Ventilator | Automatically ventilates the patient when required |
| Scavenging system | Collects and removes waste anesthetic gases to prevent operating room pollution |
| Oxygen analyzer | Only monitor that checks the LPC integrity - monitors actual O₂ delivered to patient |
| Assessment | Test | Difficult Airway Prediction |
|---|---|---|
| Mallampati score | Visualize mouth opening in sitting position | Class III-IV = difficult laryngoscopy |
| Thyromental distance | Chin to thyroid cartilage | < 6 cm = difficult |
| Mouth opening (IID) | Interincisor distance | < 3 cm = difficult |
| Neck movement | Atlanto-occipital extension | Restricted = difficult |
| ULBT | Upper lip bite test | Unable to bite upper lip = difficult |
| BMI / Obesity | - | Higher difficulty; use ramped position |
| Device | Description | When Used |
|---|---|---|
| Oropharyngeal Airway (OPA) | Guedel airway - rigid curved device | Unconscious patients only - causes gag reflex if awake |
| Nasopharyngeal Airway (NPA) | Soft rubber tube via nostril | Can be used in semi-conscious patients. Contraindicated in basal skull fracture |
| LMA (Classic) | Cuff-sealed supraglottic airway | Short procedures, spontaneous ventilation, rescue device. Sizes 1-5 by weight. |
| LMA ProSeal | Modified LMA with gastric drainage port | Better seal for positive pressure ventilation; allows gastric tube passage |
| ETT (Endotracheal Tube) | Cuffed tube into trachea | Definitive airway. Protects against aspiration. Required for PPV and major surgery. |
| Double-lumen tube | Two-lumen tube (left/right) | One-lung ventilation in thoracic surgery |
| Tracheostomy tube | Tube through surgical tracheal opening | Long-term airway management, failed intubation |
| Blade | Shape | Technique | Best For |
|---|---|---|---|
| Macintosh | Curved | Tip in vallecula (between epiglottis and tongue base) | Adults - most common |
| Miller | Straight | Tip lifts epiglottis directly | Neonates, infants; anterior larynx |
| Grade | View |
|---|---|
| Grade I | Full view of vocal cords |
| Grade II | Partial view of cords |
| Grade III | Only epiglottis visible |
| Grade IV | Not even epiglottis visible |
| Phase | Drug | Dose |
|---|---|---|
| Pre-med | Midazolam | 7.5-15 mg oral OR 0.025-0.1 mg/kg IV |
| Pre-med (antisecretion) | Glycopyrrolate | 0.2-0.4 mg IM |
| Induction | Propofol | 1.5-2.5 mg/kg IV |
| Induction (emergency/hemodynamic instability) | Ketamine | 1-2 mg/kg IV |
| Induction (hemodynamically unstable) | Etomidate | 0.3 mg/kg IV |
| Intubation (RSI) | Succinylcholine | 1.5 mg/kg IV |
| Intubation (elective) | Rocuronium | 0.6 mg/kg IV |
| Intraop analgesia | Fentanyl | 1-3 mcg/kg IV bolus |
| Maintenance (volatile) | Sevoflurane | 1-2% (with N₂O/O₂) |
| Maintenance (TIVA) | Propofol infusion | 4-10 mg/kg/hr |
| Reversal of block | Neostigmine + Glycopyrrolate | 0.05 mg/kg + 0.01 mg/kg IV |
| Reversal of rocuronium | Sugammadex | 2-4 mg/kg IV |
| Spinal anesthesia | Bupivacaine 0.5% heavy | 2-3 ml (10-15 mg) |